Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

How does renal function impact tigecycline's liver safety?
Symbravo medication information ema europa eu?
Is allopurinol expensive?
When will tenofovir alafenide come off patent in canada?
Dabrafenib patent expiration date novartis gsk composition matter?

Which types of cancer did polivy's clinical trials focus on?

See the DrugPatentWatch profile for polivy

Which cancers did Polivy’s clinical trials enroll patients with?

Polivy (polatuzumab vedotin) clinical trials focused on cancers that express CD79b, most notably:

- Diffuse large B-cell lymphoma (DLBCL), including relapsed or refractory DLBCL [1].
- Follicular lymphoma (FL), including relapsed or refractory FL [1].

Did Polivy also test other lymphoma subtypes?

Across the provided trial information, Polivy’s studies are described for B-cell lymphomas—specifically DLBCL and FL—rather than other cancer types [1].

Were these trials in solid tumors or mainly blood cancers?

The clinical trial focus described for Polivy is mainly on blood cancers (B-cell non-Hodgkin lymphomas), not solid tumors [1].

Where can I see the exact trial descriptions?

The cancers above come from Polivy’s clinical-trial focus as summarized in the provided source [1].

Sources:
[1] https://www.roche.com/investors/earnings/earnings-presentations/2020/polivy-growth-strategy.html



Other Questions About Polivy :

How did polivy control variables in assessing treatment efficacy? Polivy? Polivy or alternatives which has fewer side effects? Polivy drug? What was the age range of polivy trial participants? At what age can one participate in polivy trials? What is the youngest age in polivy trials?